Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashten Omstead

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Proteome Research|December 16, 2025
Peptide-Level Biomarker as a New Direction for Blood-Based Testing: Evaluation of Plasma Proteome Variability Induced by Prolonged on-Ice StorageXi Peng, Qiangmin Zhang, Ashten Omstead, et al.
Cancers|November 13, 2025
Blood-Based Surveillance Biomarkers for Gastroesophageal CancersNeda Dadgar, Muhammad Anees, Christopher Sherry, et al.
Clinical and Translational Medicine|March 23, 2026
Liquid biopsy biomarkers for early detection of gastrointestinal cancers: Current landscape and emerging technologiesMuhammad Anees, Christopher Sherry, Hyun Y Park, et al.
Cancers|February 13, 2025
Intra-Tumoral CD8+:CD3+ Lymphocyte Density Ratio in Appendix Cancer Is a Tumor Volume- and Grade-Independent Predictor of SurvivalChelsea Knotts, Hyun Park, Christopher Sherry, et al.
Annals of Surgery|October 8, 2015
Preclinical Study of AUY922, a Novel Hsp90 Inhibitor, in the Treatment of Esophageal AdenocarcinomaJuliann E Kosovec, Ali H Zaidi, Lori A Kelly, et al.
Annals of Surgical Oncology|March 14, 2026
Integrated Liquid Biopsy and Tumor Tissue Genomic Profiling of Appendiceal Cancer: cfDNA Burden, Mutation Landscapes, and Clinical OutcomesSefali Patel, Patricia Petrosko, Phillip H Gallo, et al.
Annals of Surgical Oncology|April 1, 2026
Publisher Correction: Integrated Liquid Biopsy and Tumor Tissue Genomic Profiling of Appendiceal Cancer: cfDNA Burden, Mutation Landscapes, and Clinical OutcomesSefali Patel, Patricia Petrosko, Phillip H Gallo, et al.
The Journal of Liquid Biopsy|July 3, 2026
Longitudinal methylated ctDNA increases predict immunotherapy progression across solid tumorsMuhammad Anees, Patrick L Wagner, Ashten Omstead, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Proteome Research|December 16, 2025
Peptide-Level Biomarker as a New Direction for Blood-Based Testing: Evaluation of Plasma Proteome Variability Induced by Prolonged on-Ice StorageXi Peng, Qiangmin Zhang, Ashten Omstead, et al.
Cancers|November 13, 2025
Blood-Based Surveillance Biomarkers for Gastroesophageal CancersNeda Dadgar, Muhammad Anees, Christopher Sherry, et al.
Clinical and Translational Medicine|March 23, 2026
Liquid biopsy biomarkers for early detection of gastrointestinal cancers: Current landscape and emerging technologiesMuhammad Anees, Christopher Sherry, Hyun Y Park, et al.
Cancers|February 13, 2025
Intra-Tumoral CD8+:CD3+ Lymphocyte Density Ratio in Appendix Cancer Is a Tumor Volume- and Grade-Independent Predictor of SurvivalChelsea Knotts, Hyun Park, Christopher Sherry, et al.
Annals of Surgery|October 8, 2015
Preclinical Study of AUY922, a Novel Hsp90 Inhibitor, in the Treatment of Esophageal AdenocarcinomaJuliann E Kosovec, Ali H Zaidi, Lori A Kelly, et al.
Annals of Surgical Oncology|March 14, 2026
Integrated Liquid Biopsy and Tumor Tissue Genomic Profiling of Appendiceal Cancer: cfDNA Burden, Mutation Landscapes, and Clinical OutcomesSefali Patel, Patricia Petrosko, Phillip H Gallo, et al.
Annals of Surgical Oncology|April 1, 2026
Publisher Correction: Integrated Liquid Biopsy and Tumor Tissue Genomic Profiling of Appendiceal Cancer: cfDNA Burden, Mutation Landscapes, and Clinical OutcomesSefali Patel, Patricia Petrosko, Phillip H Gallo, et al.
The Journal of Liquid Biopsy|July 3, 2026
Longitudinal methylated ctDNA increases predict immunotherapy progression across solid tumorsMuhammad Anees, Patrick L Wagner, Ashten Omstead, et al.
Pageof 1